Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China flag China · Delayed Price · Currency is CNY
26.09
-0.20 (-0.76%)
Nov 13, 2026, 3:00 PM CST

SHA:688566 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
240.62261.61219.33219.09154.67114.9
Depreciation & Amortization
17.7117.7110.711.212.7512.98
Other Amortization
0.750.750.81.071.091.09
Loss (Gain) From Sale of Assets
----0.01-
Loss (Gain) From Sale of Investments
0.810.8140.850.48-5.68-17.26
Provision & Write-off of Bad Debts
-2.62-2.622.267.20.73-1.77
Other Operating Activities
75.71-1.67-0.591.81-0.4-0.55
Change in Accounts Receivable
-61-61-24.28-138.14-72.0842.96
Change in Inventory
3.613.61-1.191.12-0.830.28
Change in Accounts Payable
11.5811.58-37.638.4739.43-8.6
Change in Other Net Operating Assets
23.0323.036.8117.8921.517.33
Operating Cash Flow
304.7248.3215.29159.5150.72150.56
Operating Cash Flow Growth
43.11%15.33%34.98%5.82%0.11%28.28%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-84.03-114.6-174.53-357.37-292.7-83.79
Sale of Property, Plant & Equipment
-0.020--0.010
Cash Acquisitions
-20.38-20.38----
Investment in Securities
-212.22-142.6-51-15108.8-270
Other Investing Activities
69.435.368.338.4120.64
Investing Cash Flow
-247.25-274.57-220.17-364.04-175.49-333.15

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-63.8539.2619.74--
Total Debt Issued
63.8563.8539.2619.74--
Total Debt Repaid
-2.2-----
Net Debt Issued (Repaid)
61.6563.8539.2619.74--
Issuance of Common Stock
19.41-222.2924.29--
Common Dividends Paid
-52.25-103.7-102.95-44.87-89.73-89.73
Other Financing Activities
-17.67--1.31-0.4--
Financing Cash Flow
11.14-39.86157.3-1.23-89.73-89.73

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
68.59-66.13152.42-205.77-114.5-272.32

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
220.67133.7140.76-197.87-141.9866.77
Free Cash Flow Growth
196.09%228.01%----28.73%
Free Cash Flow Margin
21.29%13.84%4.55%-22.98%-21.68%13.10%
Free Cash Flow Per Share
1.100.670.21-1.06-0.760.35
Levered Free Cash Flow
229.8575.19-10.03-303.05-187.7385.4
Unlevered Free Cash Flow
229.9375.36-9.95-302.99-187.585.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
183.93152.97141.4293.8383.3683.52
Change in Working Capital
-28.28-28.28-58.05-81.35-12.4441.18